News and Trends 23 Nov 2022
Tevogen Bio to investigate T cell therapy in long Covid
Tevogen Bio is set to study the potential therapeutic use of its investigational Covid-19 T cell therapy, TVGN-489, in long Covid. The finding that none of the patients in the…